These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20092879)

  • 21. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
    Kim SH; Kim TB; Kim SW; Oh SJ
    J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging and overactive bladder may be associated with loss of urethral sensation in women.
    Kenton K; Lowenstein L; Simmons J; Brubaker L
    Neurourol Urodyn; 2007; 26(7):981-4. PubMed ID: 17626276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitive or Detrusor Overactivity: Which is Associated with Filling Symptoms in Female Bladder Outlet Obstructed Patients.
    Zhang J; Cao M; Chen Y; Liang W; Liang Y
    Urol J; 2019 Jun; 16(3):285-288. PubMed ID: 30882167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
    Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
    Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging bladder sensations.
    Griffiths D
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):899-903. PubMed ID: 17654564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
    Al-Zahrani AA; Gajewski JB
    BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome.
    Philip J; Willmott S; Owen D; Samsudin C; Irwin PP
    Neurourol Urodyn; 2007; 26(1):110-4. PubMed ID: 17009304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.